Professor of Medicine/Oncology
University of Michigan
Univ. Michigan
Ann Arbor, Michigan, United States
Ulka Vaishampayan, MD, is a Professor of Internal Medicine, Leader of the Translational and Clinical Research Program and the Director of the Phase 1 Program at the University of Michigan Rogel Cancer Center. She serves as the Chair of the SWOG Advanced Renal Committee, a member of the National Cancer Institute (NCI) Renal Task Force, and a board member of the Michigan Society of Hematology/Oncology. Dr. Vaishampayan specializes in the treatment of genitourinary malignancies, including prostate cancer, bladder cancer, and renal cell carcinoma, and her research focuses on translational drug development. She is PI of the Dept of Defense Kidney Cancer Consortium site and is a recipient of the Prostate cancer Foundation Challenge Award. She has completed leadership training and has acquired the prestigious Fellowship of the Advisory Board (FAB).
Disclosure information not submitted.
Beyond first-line therapy: Selecting further lines of therapies after IO-IO
Saturday, April 22, 2023
09:02 – 09:12 GMT
Saturday, April 22, 2023
10:00 – 11:00 GMT
Saturday, April 22, 2023
10:50 – 11:00 GMT
Saturday, April 22, 2023
16:11 – 16:23 GMT